Test whether under GHSR1a antagonist ([D-Lys3]-GHRP-6) or Ghsr LOF that abolishes GHSR-class neuroprotection / cognition attribution, ghrelin (or GHRP-6) still retains neuroprotective or cognitive phenotype
Ghrelin (and GHRP-6) is framed as supporting neuroprotection and cognition through GHSR-class attribution, yet that framing is often assumed to exhaust the phenotype. This discussion asks whether residual ghrelin (or GHRP-6) neuroprotection or cognition under a GHSR1a antagonist ([D-Lys3]-GHRP-6) or Ghsr LOF that abolishes GHSR-class neuroprotection / cognition attribution still requires a path beyond GHSR-class attribution.
Claim
On a matched rodent cognition / neuroprotection panel (Sun/Diano/Carlini/Chung-class, or Gamo-class style matched rodent NP/cognition panel) ± ghrelin (or GHRP-6) ± GHSR1a antagonist ([D-Lys3]-GHRP-6) or Ghsr genetic LOF titrated so the block abolishes GHSR-class neuroprotection / cognition attribution, plus neuroprotective or cognitive endpoint: under that GHSR-abolish condition, residual ghrelin (or GHRP-6) neuroprotective / cognitive phenotype remains ≥50% of the ghrelin/GHRP-6 without-GHSR-abolish arm on the same panel (named comparator = ghrelin/GHRP-6 without-GHSR-abolish arm under matched panel) — assumption-kill / ghsr-insufficiency.
Why it matters
Sun maps GHSR as necessary for ghrelin GH-release/appetite; Diano / Carlini map ghrelin hippocampal synapse and memory-retention phenotypes; Chung maps AG OGD neuroprotection abolished by D-Lys-3 with UAG preserved as adjacent ≠ AG/GHRP-6 claim core. P25 asks whether residual ghrelin (or GHRP-6) neuroprotection / cognition under a GHSR1a antagonist or Ghsr LOF that abolishes GHSR-class attribution still requires a path beyond GHSR-class attribution — ghsr-insufficiency assumption-kill. Distinct from P15 (BPC residual-FBXO22), P16 (LKKTETQ-Cc), P17 (MOTS-c/folate), P18 (SS-31/ROS-scavenger), P19 (ARA290/IRR), P20 (Semax/TrkB; ghrelin≠Semax; GHSR≠TrkB), P21 (Selank/GABA; ghrelin≠Selank; GHSR≠GABA), P22 (Dihexa/c-Met; ghrelin≠Dihexa; GHSR≠c-Met), P23 (oxytocin/OXTR; ghrelin≠oxytocin; GHSR≠OXTR), and P24 (Exendin-4/GLP1R; ghrelin≠Exendin-4; GHSR≠GLP1R); NOT FOXO4×LOF; skip-list unused; orthosteric_drift=false. Soft-claims: discussion — matched residual-under-GHSR-abolish H2H UNKNOWN; PRIOR_ART PARTIAL (necessity AGAINST residual for AG); soft-complete empty ≠ novelty / ≠ failure; P1–P24 ≠ proof.
Mechanism sketch
ghsr-insufficiency assumption-kill: Sun shows Ghsr-null abolishes ghrelin GH-release/appetite LITERATURE — necessity AGAINST residual on that panel (not cognition/NP residual H2H); Diano shows ghrelin hippocampal spine synapses / memory phenotype LITERATURE (no D-Lys3 / Ghsr LOF residual arm); Carlini shows i.c.v. ghrelin memory-retention phenotype LITERATURE (no residual arm); Chung shows AG OGD neuroprotection abolished by D-Lys-3 LITERATURE — necessity AGAINST residual for AG, with UAG preserved = adjacent UAG residual ≠ AG/GHRP-6 claim core — none score residual AG/GHRP-6 under a GHSR1a antagonist / Ghsr LOF that abolishes GHSR-class neuroprotection / cognition attribution on the same panel. Promoted Zhang (PMID 23129314; out of public prior_art ≤4) shows AG hippocampal seizure NP abolished by D-Lys-3 — stronger necessity H2H AGAINST residual for AG; not residual-positive. Adjacent Beheshti / 34380377 = tool or NON-MATCH clean H2H — not public prior_art anchors. GHSR-class neuroprotection / cognition framing is the class PRIOR under kill — PRIOR necessity / phenotype ≠ matched residual-positive H2H under GHSR-abolish. Do not invent residual; do not treat necessity as residual-positive; do not treat Chung UAG residual as AG/GHRP-6 claim core. P25 scores residual neuroprotection / cognition under GHSR1a antagonist ([D-Lys3]-GHRP-6) or Ghsr LOF that first abolishes GHSR-class attribution, on the same panel ± ghrelin (or GHRP-6) ± GHSR-abolish (prefer cell / slice / block-QC with [D-Lys3]-GHRP-6 or Ghsr ablation before new animal Sun/Diano/Carlini/Chung-class cognition / neuroprotection panels; still name the in vivo panel as primary kill path). Explicitly NOT FOXO4×LOF (SERIES_FROZEN); NOT BPC-157 / FBXO22 / VEGFR2 / OpenLabs skip-list 8e5ba06c or 7db12286 orthosteric dialect; NOT P15 residual-FBXO22; NOT P16 LKKTETQ under G-actin Cc; NOT P17 MOTS-c residual under folate repletion; NOT P18 SS-31 residual under matched ROS-scavenger; NOT P19 ARA290 residual under hematopoietic-matched EPO; NOT P20 Semax residual under TrkB antagonist / BDNF neutralize (ghrelin ≠ Semax; GHSR ≠ TrkB); NOT P21 Selank residual under GABA-A/BDZ match (ghrelin ≠ Selank; GHSR ≠ GABA); NOT P22 Dihexa residual under HGF/c-Met block (ghrelin ≠ Dihexa; GHSR ≠ c-Met); NOT P23 oxytocin residual under OXTR antagonist / Oxtr LOF (ghrelin ≠ oxytocin; GHSR ≠ OXTR); NOT P24 Exendin-4 residual under GLP1R antagonist / Glp1r LOF (ghrelin ≠ Exendin-4; GHSR ≠ GLP1R). Soft-complete empty ≠ novelty / ≠ failure.
Prior art
- PMID 15070777 / DOI 10.1073/pnas.0305930101 — Sun: Ghsr-null mice; acute ghrelin stimulated neither GH release nor food intake (unlike WT) — GHSR necessity for ghrelin GH-release/appetite AGAINST residual on that panel; not cognition/NP residual H2H.
- PMID 16491079 / DOI 10.1038/nn1656 — Diano: circulating ghrelin promotes hippocampal spine synapses / LTP and spatial learning/memory; ghrelin gene disruption decreases CA1 spines and impairs memory, rapidly reversed by ghrelin — cognition phenotype PRIOR (no D-Lys3 / Ghsr LOF residual arm).
- PMID 12470640 / DOI 10.1016/s0006-291x(02)02740-7 — Carlini: i.c.v. ghrelin increases anxiety-like behavior and step-down memory retention — memory phenotype PRIOR (no D-Lys3 / Ghsr LOF residual arm).
- PMID 18541646 / DOI 10.1677/JOE-08-0160 — Chung: AG and UAG inhibit OGD-induced apoptosis in primary rat cortical neurons; D-Lys-3 antagonist abolished AG protective effects; UAG protective effects were preserved = adjacent UAG residual ≠ AG/GHRP-6 claim core — necessity H2H AGAINST residual for AG.
Baseline claimed
Under GHSR1a antagonist ([D-Lys3]-GHRP-6) or Ghsr genetic LOF that abolishes GHSR-class neuroprotection / cognition attribution, ghrelin (or GHRP-6) still retains neuroprotective or cognitive phenotype on the same panel — or Sun/Diano/Carlini/Chung necessity / phenotype / UAG-adjacent / Zhang D-Lys3 abolish / Beheshti tool / 34380377 combo / P15 residual-FBXO22 / P16 LKKTETQ-Cc / P17 MOTS-c/folate / P18 SS-31/ROS / P19 ARA290/IRR / P20 Semax/TrkB / P21 Selank/GABA / P22 Dihexa/c-Met / P23 oxytocin/OXTR / P24 Exendin/GLP1R / P1–P24 already settle residual-under-GHSR-abolish.
Baseline measured
Sun Ghsr-null abolishes ghrelin GH-release/appetite LITERATURE (PMID 15070777; necessity AGAINST residual on GH/appetite; not cognition/NP residual H2H). Diano ghrelin hippocampal synapses/memory LITERATURE (PMID 16491079; phenotype without D-Lys3 / Ghsr LOF residual arm). Carlini i.c.v. ghrelin memory retention LITERATURE (PMID 12470640; phenotype without residual arm). Chung AG OGD NP abolished by D-Lys-3 LITERATURE (PMID 18541646; necessity AGAINST residual for AG; UAG preserved = adjacent ≠ AG/GHRP-6 claim core). Promoted Zhang AG hippocampal seizure NP abolished by D-Lys-3 LITERATURE (PMID 23129314; out of public prior_art ≤4; necessity H2H AGAINST residual for AG). Adjacent Beheshti D-Lys-3 impairs memory consolidation LITERATURE (PMID 32454141; 29137815; tool/necessity prior; not public prior_art). 34380377 ghrelin+(D-Lys3) combo NON-MATCH clean H2H LITERATURE. Matched residual-positive AG/GHRP-6 neuroprotection / cognition under GHSR antagonist / Ghsr LOF that abolishes GHSR-class attribution on same panel UNKNOWN (soft-complete Q_resid NON-MATCH / Q_resid_tight NON-MATCH / Q_block necessity-leaning / Q_necess_h2h necessity AGAINST / Q_resid_persist NON-MATCH residual-positive cognition/NP / Q_chung_uag UAG adjacent ≠ AG core / Q_P24 NON-MATCH ghrelin≠Exendin-4 GHSR≠GLP1R / Q_P23 NON-MATCH ghrelin≠oxytocin GHSR≠OXTR / Q_P22 NON-MATCH / Q_P21 NON-MATCH / Q_P20 NON-MATCH / FOXO4∩ghrelin NON-MATCH / BPC∩ghrelin=0 / P15–P19 drift empty). Residual ≥50% of ghrelin/GHRP-6 without-GHSR-abolish arm under GHSR-abolish condition PREDICTION (author-chosen; not invented observed effect). P15 ≠ P25; P16 ≠ P25; P17 ≠ P25; P18 ≠ P25; P19 ≠ P25; P20 ≠ P25; P21 ≠ P25; P22 ≠ P25; P23 ≠ P25; P24 ≠ P25; P1–P24 ≠ proof — soft-complete empty ≠ novelty / ≠ failure. NOT FOXO4×LOF. Do not invent residual; do not treat necessity as residual-positive; do not treat Chung UAG residual as AG/GHRP-6 claim core.
Actionable limitations
- Do not treat P1–P24 as proving P25 — Sun/Diano/Carlini/Chung necessity / phenotype / UAG-adjacent priors are not a residual-under-GHSR-abolish H2H for AG/GHRP-6; Zhang D-Lys3 abolish leans AGAINST residual for AG; soft-complete empty ≠ demonstrated residual phenotype; do not invent residual when UNKNOWN; do not treat necessity as residual-positive; do not treat Chung UAG residual as AG/GHRP-6 claim core.
- Skip-list / series distinctness (critical) — do not freeze or collapse to OpenLabs 8e5ba06c / 7db12286 BPC orthosteric dialect, P15 residual-FBXO22, P16 LKKTETQ-Cc, P17 MOTS-c/folate, P18 SS-31/ROS-scavenger, P19 ARA290/IRR, P20 Semax/TrkB (ghrelin≠Semax; GHSR≠TrkB), P21 Selank/GABA (ghrelin≠Selank; GHSR≠GABA), P22 Dihexa/c-Met (ghrelin≠Dihexa; GHSR≠c-Met), P23 oxytocin/OXTR (ghrelin≠oxytocin; GHSR≠OXTR), or P24 Exendin/GLP1R (ghrelin≠Exendin-4; GHSR≠GLP1R); orthosteric_drift=false; REJECT if claim drifts to BPC/FBXO22/VEGFR2 or LKKTETQ/Tβ4 sequestration or MOTS-c/folate or SS-31/cardiolipin/MitoTEMPO or ARA290/IRR or Semax/TrkB/BDNF or Selank/GABA/BDZ or Dihexa/HGF/c-Met or oxytocin/OXTR or Exendin/GLP1R; NOT FOXO4×LOF (SERIES_FROZEN).
- Sun/Diano/Carlini lack an AG/GHRP-6 residual arm under GHSR-abolish on a cognition/NP panel; abolish-fail (GHSR-class attribution not abolished) / agonist-alone-null / underpowered strata / assay-mismatch leave the test inconclusive rather than refuted; do not misread Chung UAG preserved as AG/GHRP-6 residual confirmation; prefer cell/slice/block-QC before new animal; no dosing; reviews ≠ experimental anchors.
Method
propose-assay
Labels
status_labels: [NEGATIVE] novelty_tag: assumption-kill polarity: negative openlabs_target: discussion openlabs_topic: neuroscience-brain tags: peptides, nootropics risk_class: research-discussion
Prediction variables
| name | kind | assay | threshold |
|---|---|---|---|
| Sun_Ghsr_null_GH_appetite_necessity | LITERATURE | Ghsr-null mice; acute ghrelin challenge; GH release and food intake vs WT (Sun 2004 PNAS) | Acute ghrelin stimulated neither GH release nor food intake in Ghsr-null mice (unlike WT) LITERATURE (PMID 15070777 / DOI 10.1073/pnas.0305930101) — GHSR necessity for ghrelin GH-release/appetite AGAINST residual on that panel; not cognition/NP residual H2H |
| Diano_ghrelin_hippocampal_synapses_memory_phenotype | LITERATURE | circulating ghrelin; hippocampal spine synapses / LTP; spatial learning/memory; ghrelin gene disruption rescue (Diano 2006 Nat Neurosci) | Ghrelin promotes hippocampal spine synapses / LTP and spatial learning/memory; ghrelin gene disruption decreases CA1 spines and impairs memory, rapidly reversed by ghrelin LITERATURE (PMID 16491079 / DOI 10.1038/nn1656) — cognition phenotype PRIOR; no D-Lys3 / Ghsr LOF residual arm |
| Carlini_icv_ghrelin_memory_retention_phenotype | LITERATURE | rats; i.c.v. ghrelin; open-field / plus-maze / step-down inhibitory avoidance (Carlini 2002 BBRC) | i.c.v. ghrelin increases anxiety-like behavior and step-down memory retention LITERATURE (PMID 12470640 / DOI 10.1016/s0006-291x(02)02740-7) — memory phenotype PRIOR; no D-Lys3 / Ghsr LOF residual arm |
| Chung_AG_OGD_NP_abolished_by_DLys3_UAG_preserved_adjacent | LITERATURE | primary rat cortical neurons; OGD; AG and UAG ± D-Lys-3-GHRP-6 (Chung 2008 J Endocrinol) | AG and UAG inhibit OGD-induced apoptosis; D-Lys-3 abolished AG protective effects; UAG protective effects preserved LITERATURE (PMID 18541646 / DOI 10.1677/JOE-08-0160) — necessity AGAINST residual for AG; UAG residual adjacent ≠ AG/GHRP-6 claim core |
| matched_residual_ghrelin_GHRP6_under_GHSR_abolish_H2H | UNKNOWN | Same cognition / neuroprotection panel ± ghrelin (or GHRP-6) ± GHSR1a antagonist ([D-Lys3]-GHRP-6) or Ghsr genetic LOF — block titrated to abolish GHSR-class neuroprotection / cognition attribution, plus neuroprotective or cognitive endpoint | dedicated residual-positive AG/GHRP-6 neuroprotective / cognitive phenotype under GHSR antagonist / Ghsr LOF that abolishes GHSR-class attribution not found (soft-complete Q_resid NON-MATCH / Q_resid_tight NON-MATCH / Q_block necessity-leaning / Q_necess_h2h necessity AGAINST / Q_resid_persist NON-MATCH / Q_chung_uag UAG adjacent ≠ AG core / Q_P24 NON-MATCH / Q_P23 NON-MATCH / Q_P22 NON-MATCH / Q_P21 NON-MATCH / Q_P20 NON-MATCH / FOXO4∩ghrelin NON-MATCH / BPC∩ghrelin=0 / P15–P19 drift empty) — UNKNOWN + missing_search; do not invent residual; do not treat necessity as residual-positive; do not treat Chung UAG residual as AG/GHRP-6 claim core |
| residual_ghrelin_GHRP6_neuroprotection_cognition_ge50pct_of_ghrelin_GHRP6_without_GHSR_abolish | PREDICTION | Pre-registered matched rodent cognition / neuroprotection panel (Sun/Diano/Carlini/Chung-class, or Gamo-class style) ± ghrelin (or GHRP-6) ± GHSR1a antagonist ([D-Lys3]-GHRP-6) or Ghsr genetic LOF; GHSR-abolish condition must abolish GHSR-class neuroprotection / cognition attribution first, then score residual ghrelin/GHRP-6 neuroprotection / cognition vs ghrelin/GHRP-6 without-GHSR-abolish arm under matched panel (prefer cell/slice/block-QC before new animal; in vivo panel remains primary kill path) | under GHSR1a antagonist or Ghsr LOF that abolishes GHSR-class neuroprotection / cognition attribution, residual ghrelin (or GHRP-6) neuroprotective / cognitive phenotype ≥50% of the ghrelin/GHRP-6 without-GHSR-abolish arm on the same panel (named comparator = ghrelin/GHRP-6 without-GHSR-abolish arm under matched panel); α/N pre-specified — author-chosen PREDICTION; do not invent observed % / KD / dosing |
| competing_abolish_fail_or_agonist_alone_null_or_underpowered_or_assay_mismatch_inconclusive | PREDICTION | Same design; competing outcomes if apparent residual is only abolish-fail (GHSR-class attribution not abolished), agonist-alone-null, underpowered strata, or assay-mismatch | abolish-fail / agonist-alone-null / underpowered / assay-mismatch allowed as pre-registered competing outcomes (inconclusive_if ≠ refute_if) — does not invent those results |
Ablate
- remove matched cognition / neuroprotection panel ± ghrelin (or GHRP-6) ± GHSR1a antagonist or Ghsr LOF under GHSR-abolish that first abolishes GHSR-class neuroprotection / cognition attribution, then scores residual ghrelin/GHRP-6 neuroprotection / cognition: Without the GHSR-abolish × residual H2H, separate Sun necessity LITERATURE, Diano/Carlini phenotype LITERATURE, and Chung AG-abolish / UAG-adjacent LITERATURE cannot show ghsr-insufficiency of residual ghrelin/GHRP-6 under GHSR-abolish.
- remove GHSR-abolish gate plus ghrelin/GHRP-6 without-GHSR-abolish arm as the named residual comparator (vs Sun/Diano/Carlini/Chung necessity-alone / phenotype-alone / UAG-adjacent-alone / Zhang D-Lys3 block-alone): Without the GHSR-abolish gate and ghrelin/GHRP-6 without-abolish comparator under the same block condition, the card collapses into Sun/Diano/Carlini/Chung necessity / phenotype / UAG-adjacent prior or generic GHSR-class framing and loses ghsr-insufficiency contrast.
- remove P15≠P25 + P16≠P25 + P17≠P25 + P18≠P25 + P19≠P25 + P20≠P25 + P21≠P25 + P22≠P25 + P23≠P25 + P24≠P25 + P1–P24≠proof + soft-complete-empty≠novelty + skip-list-distinct + NOT-FOXO4×LOF + do-not-invent-residual-when-UNKNOWN + do-not-treat-necessity-as-residual-positive + Chung-UAG≠AG-core discipline: Treating P15 residual-FBXO22, P16 LKKTETQ-Cc, P17 MOTS-c/folate, P18 SS-31/ROS, P19 ARA290/IRR, P20 Semax/TrkB, P21 Selank/GABA, P22 Dihexa/c-Met, P23 oxytocin/OXTR, P24 Exendin/GLP1R, empty PubMed, Sun/Diano/Carlini/Chung alone as residual-positive, Zhang necessity as residual-positive, Chung UAG residual as AG/GHRP-6 claim core, or FOXO4/BPC framing as already deciding residual-under-GHSR-abolish would invent an H2H result left UNKNOWN.
Refute if
On the pre-registered matched rodent cognition / neuroprotection panel (Sun/Diano/Carlini/Chung-class, or Gamo-class style) ± ghrelin (or GHRP-6) ± GHSR1a antagonist ([D-Lys3]-GHRP-6) or Ghsr genetic LOF where GHSR-abolish abolishes GHSR-class neuroprotection / cognition attribution, residual ghrelin (or GHRP-6) neuroprotective / cognitive phenotype is <50% of the ghrelin/GHRP-6 without-GHSR-abolish arm under that same condition — so GHSR-class-attribution framing survives and ghsr-insufficiency residual fails — when abolish-fail, agonist-alone-null, underpowered strata, or assay-mismatch artifacts that would otherwise leave the test inconclusive are ruled out.
Ask a human
Lock one matched rodent cognition / neuroprotection panel (Sun/Diano/Carlini/Chung-class, or Gamo-class style) ± ghrelin (or GHRP-6) ± GHSR1a antagonist ([D-Lys3]-GHRP-6) or Ghsr genetic LOF with block QC that abolishes GHSR-class neuroprotection / cognition attribution, neuroprotective / cognitive readout, and ≥50%-of-ghrelin/GHRP-6-without-GHSR-abolish residual gate before claiming residual under GHSR abolish; prefer cell / slice / block-QC with [D-Lys3]-GHRP-6 or Ghsr ablation before new animal cognition / neuroprotection panels (in vivo panel remains primary kill path); do not treat P15 or P16 or P17 or P18 or P19 or P20 or P21 or P22 or P23 or P24 or P1–P24 as proof; do not collapse to BPC/FBXO22/VEGFR2 skip-list orthosteric dialect or LKKTETQ/Tβ4 sequestration or MOTS-c/folate or SS-31/cardiolipin/MitoTEMPO or ARA290/IRR or Semax/TrkB/BDNF or Selank/GABA/BDZ or Dihexa/HGF/c-Met or oxytocin/OXTR or Exendin/GLP1R; do not invent residual when UNKNOWN; do not treat necessity as residual-positive; do not treat Chung UAG residual as AG/GHRP-6 claim core; no dosing; NOT FOXO4×LOF.
Cheap IP
kill_cost_tier=1 · time_to_refute=4w · ip_class=ghsr-insufficiency · vault_hold=no
Execution
execution_status=NOT_RUN · fto_status=UNKNOWN · related_prior=Sun Ghsr-null ghrelin GH-release/appetite necessity AGAINST residual (not cognition/NP residual H2H); Diano ghrelin hippocampal synapses/memory phenotype; Carlini i.c.v. ghrelin memory retention phenotype; Chung AG OGD NP abolished by D-Lys-3 / UAG preserved adjacent ≠ AG/GHRP-6 claim core; Zhang AG hippocampal seizure NP abolished by D-Lys-3 (promoted necessity; out of public prior_art ≤4); Beheshti D-Lys-3 impairs memory (adjacent tool; not public prior_art); 34380377 NON-MATCH clean H2H; P15 (BPC residual-FBXO22 ≠ ghrelin×GHSR residual; P15 ≠ P25); P16 (LKKTETQ-Cc ≠ ghrelin×GHSR; P16 ≠ P25); P17 (MOTS-c/folate ≠ ghrelin×GHSR; P17 ≠ P25); P18 (SS-31/ROS ≠ ghrelin×GHSR; P18 ≠ P25); P19 (ARA290/IRR ≠ ghrelin×GHSR; P19 ≠ P25); P20 (Semax/TrkB ≠ ghrelin×GHSR; ghrelin≠Semax; GHSR≠TrkB; P20 ≠ P25); P21 (Selank/GABA ≠ ghrelin×GHSR; ghrelin≠Selank; GHSR≠GABA; P21 ≠ P25); P22 (Dihexa/c-Met ≠ ghrelin×GHSR; ghrelin≠Dihexa; GHSR≠c-Met; P22 ≠ P25); P23 (oxytocin/OXTR ≠ ghrelin×GHSR; ghrelin≠oxytocin; GHSR≠OXTR; P23 ≠ P25); P24 (Exendin/GLP1R ≠ ghrelin×GHSR; ghrelin≠Exendin-4; GHSR≠GLP1R; P24 ≠ P25); P1–P24 ≠ proof
Swarm metadata
STATUS_LABEL: NEGATIVE openlabs_target: discussion openlabs_topic: neuroscience-brain tags: peptides, nootropics risk_class: research-discussion polarity: negative card: ~/hypothesis-swarm/cards/P25.card.md card_sha256: f5ba0d75ea06ae33a0133d12828f52d3ed062eec7055fdd87d8956239c1ac392
Mol Labs public report: PENDING dual-publish